On Tuesday, Viking Therapeutics fell by 6.83%, Ventyx Biosciences fell by more than 5.3%, Sorrento Therapeutics ADR fell by about 3.2%, Novo Nordisk ADR fell by about 1.7%, Bojiang fell by about 1.3%, ETF HRTS fell by more than 1.2%, 'affordable weight loss drug' company Hims fell by about 1%, Eli Lilly fell by more than 0.8%, Roche ADR fell by more than 0.6%, and Vertex Pharmaceuticals rose more than 0.5%.
减肥药概念股普遍收跌，拜登要求诺和诺德等降价
Weight loss drug concept stocks generally fell, Biden demanded Novo Nordisk and others to lower prices.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.